Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Swiss Exchange  >  Roche Holding AG    ROG   CH0012032048

ROCHE HOLDING AG

(ROG)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations
Sector news Pharmaceuticals - NEC
02:43pPfizer-BioNTech agree to supply WHO co-led COVID-19 vaccine scheme -sources
RE
01:52pCIPLA : NY governor investigates price jump in six drugs during pandemic
RE
11:31aIndia to begin commercial vaccine exports with shipments to Brazil, Morocco
RE
10:48aSouth Africa to pay $5.25 a dose for AstraZeneca vaccine from India's SII
RE
10:45aPFIZER INC : Goldman Sachs reiterates its Neutral rating
MD
10:07aCOVID-19 vaccine production unaffected by deadly Indian fire, company says
RE
08:14aLilly Antibody Drug Prevents Covid-19 in Nursing Homes, Study Finds
DJ
06:28aADDEX THERAPEUTICS : Janssen Gets FDA Approval to Begin Proof of Concept Study
DJ
05:50aMERCK KGAA : Kepler Cheuvreux remains its Buy rating
MD
05:30aIndian Shares Pull Back on Thursday Closing; Hindustan Zinc Falls 5%
MT
05:10aSANOFI : Beximco Pharmaceuticals to Buy Sanofi's Majority Stake in Bangladesh Un..
DJ
05:09aMERCK KGAA : Bernstein remains Neutral
MD
02:29aNomura Adjusts CSPC Pharmaceutical Group's Price Target to HK$12 From HK$19.8..
MT
02:24aNOVARTIS AG : Goldman Sachs reiterates its Buy rating
MD
02:11aMERCK KGAA : JP Morgan maintains a Buy rating
MD
01:49aMERCK KGAA : UBS reaffirms its Neutral rating
MD
01/20PFIZER : Correction to Europe Pfizer-BioNTech Vaccine Supply Article
DJ
01/20PFIZER : Europeans Clash With Pfizer, BioNTech Over Covid-19 Vaccine Deliveries
DJ
01/20McKesson to replace some Moderna COVID-19 vaccines due to low temperature
RE
01/20Oxford scientists preparing vaccine versions to combat emerging virus variant..
RE
01/20WHO plans slew of COVID-19 vaccine approvals for global rollout
RE
01/20TAKEDA PHARMACEUTICAL : Brazil antitrust regulator clears hurdle for Hypera-Take..
RE
01/20MERCK KGAA : Credit Suisse gives a Buy rating
MD
01/20Three COVID-19 vaccines under final review for emergency use - WHO
RE
01/20GLAXOSMITHKLINE : Goldman Sachs maintains a Buy rating
MD
01/20MERCK KGAA : Sell rating from Goldman Sachs
MD
01/20Glass maker Schott predicts enough vials to go around for COVID-19 vaccines
RE
01/20MERCK : Shares Fall After Announcement of Cancer-Drug Trial Interruption
DJ
01/20MERCK KGAA : Receives a Buy rating from JP Morgan
MD
01/20ANALYSIS : A 'buy' is just a tap away - stock market dabblers drive trading boom..
RE
01/20Merck KGaA, GSK suffer lung cancer drug setback
RE
01/20WHO plans slew of COVID-19 vaccine approvals for global rollout - document
RE
01/20JOHNSON & JOHNSON : UBS Adjusts Price Target on Johnson & Johnson to $170 From $..
MT
01/20ASTRAZENECA : India, 'pharmacy of the world', starts COVID vaccine shipments to ..
RE
01/20PRESS RELEASE : Pfizer and BioNTech Publish -3-
DJ
01/20PRESS RELEASE : Pfizer and BioNTech Publish -2-
DJ
01/20PRESS RELEASE : Pfizer and BioNTech Publish Results of Study Showing COVID-19 Va..
DJ
01/20BRISTOL MYERS SQUIBB : Gets FDA Priority Review for Two Opdivo Indications
DJ
01/20'Don't plan for the future' based on virus-driven volatility - trading platfo..
RE
01/20MERCK : Gets FDA Approval for Verquvo
DJ
01/20MERCK : stops lung cancer trial testing drug hopeful bintrafusp alfa
RE
01/20BAYER : Gets FDA Approval for Heart-Failure Drug Vericiguat
DJ
01/20GLAXOSMITHKLINE : UBS gives a Neutral rating
MD
01/20GLAXOSMITHKLINE : Credit Suisse Downgrades GSK To Underperform From Neutral, Low..
MT
01/20Russia files Sputnik V vaccine registration in Europe
RE
01/20MERCK KGAA : Buy rating from Credit Suisse
MD
01/20BAYER AG : Credit Suisse sticks Neutral
MD
01/20ASTRAZENECA : Receives a Buy rating from Credit Suisse
MD
01/20SANOFI : Credit Suisse reaffirms its Buy rating
MD
01/20NOVARTIS AG : Credit Suisse reiterates its Neutral rating
MD
1  2  3  4  5  6  7  8  9  10Next